Prof. Dr Kouzarides and his co-workers from Cancer Research Gurdon Institute, University of Cambridge, UK report in the prestigious journal Molecular Cell (2014) that “The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31”
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Insights into the targeting of cancer progression: The Breast Cancer Oncogene EMSY increases the expression of SATB2 via down regulation of its target gene.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Insights into the targeting of cancer progression: The Breast Cancer Oncogene EMSY increases the expression of SATB2 via down regulation of its target gene, 8/March/2014, 22.02, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
